Type Whole antibody Target Sclerostin Legal status Investigational | Source Humanized (from mouse) ATC code none CAS Number 909395-70-6 | |
Romosozumab (AMG 785) is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis.
Romosozumab was originally discovered by Celltech (now owned by UCB). Celltech entered in a partnership with Amgen in 2002 for the product's development.
References
Romosozumab Wikipedia(Text) CC BY-SA